[{"Assets_0_FY_USD":189328000.0,"CommonStockSharesOutstanding_0_FY_shares":48837060.0,"EarningsPerShareBasic_4_FY_USD":0.37,"EarningsPerShareBasic_1_FY_USD":0.81,"EarningsPerShareDiluted_1_FY_USD":0.8,"EarningsPerShareDiluted_4_FY_USD":0.36,"NetIncomeLoss_4_FY_USD":17859000.0,"NetIncomeLoss_1_FY_USD":39655000.0,"StockholdersEquity_0_FY_USD":79267000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":49615.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":48413.0,"Ticker":"CCXI","CIK":"1340652","name":"CHEMOCENTRYX, INC.","OfficialName":"ChemoCentryx Inc. Common Stock","form":"10-K","period":"20171231","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1508212562.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180312"}]